Liaoning Chengda Valuation
| 688739 Stock | 27.32 0.43 1.60% |
At this time, the firm appears to be overvalued. Liaoning Chengda Bio secures a last-minute Real Value of USD22.64 per share. The latest price of the firm is USD27.32. Our model forecasts the value of Liaoning Chengda Bio from analyzing the firm fundamentals such as Current Valuation of 5.86 B, return on equity of 0.0346, and Profit Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.1727 | Enterprise Value 5.9 B | Enterprise Value Ebitda 13.6015 | Price Sales 6.6221 | Trailing PE 33.7284 |
Overvalued
Today
Please note that Liaoning Chengda's price fluctuation is not too volatile at this time. Calculation of the real value of Liaoning Chengda Bio is based on 3 months time horizon. Increasing Liaoning Chengda's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Liaoning Chengda is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Liaoning Stock. However, Liaoning Chengda's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.32 | Real 22.64 | Hype 27.32 | Naive 26.57 |
The real value of Liaoning Stock, also known as its intrinsic value, is the underlying worth of Liaoning Chengda Bio Company, which is reflected in its stock price. It is based on Liaoning Chengda's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Liaoning Chengda's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Liaoning Chengda Biotechnology helps investors to forecast how Liaoning stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Liaoning Chengda more accurately as focusing exclusively on Liaoning Chengda's fundamentals will not take into account other important factors: Liaoning Chengda Cash |
|
Liaoning Chengda Total Value Analysis
Liaoning Chengda Biotechnology is presently forecasted to have takeover price of 5.86 B with market capitalization of 11.38 B, debt of 4.86 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Liaoning Chengda fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.86 B | 11.38 B | 4.86 M |
Liaoning Chengda Investor Information
About 61.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.17. In the past many companies with similar price-to-book ratios have beat the market. Liaoning Chengda Bio last dividend was issued on the 20th of June 2024. Based on the key measurements obtained from Liaoning Chengda's financial statements, Liaoning Chengda Biotechnology is performing exceptionally good at this time. It has a great odds to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 530.1 M | 677 M |
|
| |||||
| Operating Income | 667.8 M | 592.7 M |
|
|
Liaoning Chengda Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Liaoning Chengda has an asset utilization ratio of 17.36 percent. This suggests that the Company is making USD0.17 for each dollar of assets. An increasing asset utilization means that Liaoning Chengda Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Liaoning Chengda Ownership Allocation
Liaoning Chengda Bio maintains a total of 416.45 Million outstanding shares. Liaoning Chengda Biotechnology secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.25 % of Liaoning Chengda Biotechnology outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Liaoning Chengda Profitability Analysis
The company reported the revenue of 1.75 B. Net Income was 465.92 M with profit before overhead, payroll, taxes, and interest of 1.57 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Liaoning Chengda's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Liaoning Chengda and how it compares across the competition.
About Liaoning Chengda Valuation
The stock valuation mechanism determines Liaoning Chengda's current worth on a weekly basis. Our valuation model uses a comparative analysis of Liaoning Chengda. We calculate exposure to Liaoning Chengda's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Liaoning Chengda's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.5 B | 1.3 B |
Liaoning Chengda Quarterly Retained Earnings |
|
Complementary Tools for Liaoning Stock analysis
When running Liaoning Chengda's price analysis, check to measure Liaoning Chengda's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Liaoning Chengda is operating at the current time. Most of Liaoning Chengda's value examination focuses on studying past and present price action to predict the probability of Liaoning Chengda's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Liaoning Chengda's price. Additionally, you may evaluate how the addition of Liaoning Chengda to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |